Socioeconomic Status in Children Tied to MetS in Adulthood

Share this content:
Socioeconomic Status in Children Tied to MetS in Adulthood
Socioeconomic Status in Children Tied to MetS in Adulthood

THURSDAY, Oct. 27, 2016 (HealthDay News) -- Family socioeconomic status (SES) in childhood is associated with the risk for metabolic syndrome (MetS) and glucose abnormalities in adulthood, according to a study published online Oct. 18 in Diabetes Care.

Elina Puolakka, Ph.D., from the University of Turku in Finland, and colleagues followed 2,250 participants from the longitudinal Cardiovascular Risk in Young Finns Study cohort (ages 3 to 18 years at baseline) for 31 years. They characterized SES as reported annual income of the family.

The researchers found that after adjustment for age, sex, childhood cardiometabolic risk factors, childhood physical activity, and fruit and vegetable consumption, for each one-unit increase in family SES in childhood, there was a decrease in the risk for adult MetS (risk ratio, 0.94). After adjustment for participants' own SES in adulthood, the correlation persisted (risk ratio, 0.95). There was a similar correlation between childhood SES and the risk of having adult impaired fasting glucose (IFG) or type 2 diabetes (risk ratio, 0.96); after adjustment for childhood risk factors, the correlation was no longer significant.

"Lower SES in childhood may be associated with an increased risk for MetS, IFG, and type 2 diabetes in adulthood," the authors write. "Special attention could be paid to children of low SES families to decrease the prevalence of MetS in adulthood."

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Approves Kinase Inhibitor for Treatment of AML

FDA Approves Kinase Inhibitor for Treatment of AML

Midostaurin, in combination with chemotherapy, treats acute myeloid leukemia in adults

Enzyme Replacement Drug OK'd for Form of Batten Disease

Enzyme Replacement Drug OK'd for Form of Batten ...

Brineura will be used to treat children with late infantile neuronal ceroid lipofuscinosis type 2 Batten

is free, fast, and customized just for you!

Already a member?

Sign In Now »